- EN
- JP
Metagen Therapeutics, Inc.
Bringing innovative medicine and pharmaceuticals to life
through cutting-edge microbiome science
News
-
【News】CSO Terauchi receives Dr.Tissier’s Medal at The 28th Annual Meeting of The Intestinal Microbiology Society
We are pleased to announce that Metagen Therapeutics CSO, Jun Terauchi received the Dr. Tissier’s Medal after […] -
【News】CSO Terauchi and COO Tamura to speak at 9th Microbiome Movement Drug Development Summit
(Yamagata, Japan, June 26, 2024) Metagen Therapeutics, Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; […] -
【News】Metagen Therapeutics Selected for AMED’s FY2024 Strengthening Program for Pharmaceutical Startup Ecosystem : 4th Call for Proposal from Pharmaceutical Startups
We are pleased to announce that our Ulcerative Colitis drug development project has been selected by AMED, Jap […] -
【News】CSO Terauchi to speak at The 28th Annual Meeting of Intestinal Microbiology
(Yamagata, Japan, June 6, 2024) Metagen Therapeutics, Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; […] -
【News】CMO Ishikawa to speak at 10th International Human Microbiome Consortium Congress 2024
(Yamagata, Japan, May 30, 2024) Metagen Therapeutics, Inc. (Headquarters: Tsuruoka City, Yamagata Prefecture; […]
Medical Services・Pipeline/Platform
The human microbiome is comprised of bacterial flora found throughout the human body, including in the intestines, skin, and oral cavity. Intestinal microbiome in particular, has a complex and dynamic population of microorganisms. In recent years, research on the intestinal flora has made significant progress and its symbiotic relationship with various diseases such as cancer, ulcerative colitis, Parkinson’s disease, and allergies, has become clear.
FMT and its research has been shown to be a safe and efficacious treatment around the world, and microbiome drug discovery is being actively carried out.
Founders
![](https://www.metagentx.com/wp-content/uploads/2021/03/founders-nakahara.jpg)
Chief Executive Officer
Taku Nakahara Ph.D., MBA
![](https://www.metagentx.com/wp-content/uploads/2021/12/founders-ishikawa.jpg)
Chief Medical Officer
Dai Ishikawa MD, Ph.D.
Associate Professor
Juntendo University,
Department of Gastroenterology,
Faculty of Medicine
![](https://www.metagentx.com/wp-content/uploads/2021/07/7f20302de6165d002b2b1ef5f9d986cf.jpeg)
![](https://www.metagentx.com/wp-content/uploads/2021/03/founders-fukuda.jpg)
Senior Scientific Advisor
Shinji Fukuda MD, Ph.D.
Project Professor
Keio University,
Institute for Advanced Biosciences
![](https://www.metagentx.com/wp-content/uploads/2021/11/top-founders-university-img01.png)
![](https://www.metagentx.com/wp-content/uploads/2021/03/founders-yamada.jpg)
Senior Scientific Advisor
Takuji Yamada Ph.D.
Associate Professor
Tokyo Institute of Technology,
School of Life Science and Technology
![](https://www.metagentx.com/wp-content/uploads/2021/07/b55de9a16b00487fb85b525359503335.png)
腸内細菌療法
メタジェンセラピューティクスはCMO石川が順天堂大学で研究してきた腸内細菌療法の普及を目指します。
Partners
![](https://www.metagentx.com/wp-content/uploads/2021/03/partner-fti.png)
![](https://www.metagentx.com/wp-content/uploads/2021/03/partner-kii.png)
![](https://www.metagentx.com/wp-content/uploads/2022/10/JAFCO_logo_black-1-1024x395.jpg)
Company
Metagen Therapeutics, Inc. (MGTx)
January 2020
Drug discovery and medical services using microbiome science
President & CEO Taku Nakahara
Director, CMO Dai Ishikawa
Director, CSO Jun Terauchi
Non-Executive Director Tomohiro Anzai
Non-Executive Director Taira Kobayashi
Non-Executive Director Jun Hayashi
Senior Scientific Advisor Shinji Fukuda
Senior Scientific Advisor Takuji Yamada
246-2 Mizukami, Kakuganji, Tsuruoka-city, Yamagata 997-0052 Japan
Toranomon Hills Business Tower 15F
1-17-1 Toranomon, Minato-ku, Tokyo 105-6415 Japan